
Loading, please wait...

Loading, please wait...

Borophene, a single layer of boron atoms, has recently captured the attention of the scientific community. This material exhibits a unique anisotropy in its crystallographic structure. Consequently, it demonstrates diverse physical and chemical behaviors. Borophene in biomedical applications is a growing field because of the material's high electronic mobility and chemical reactivity. While researchers have already explored metallic β and semiconducting α phases, new crystallographic phases are currently under investigation. These variations allow for specialized uses in next-generation medical devices.
Despite its potential, borophene faces significant hurdles before widespread clinical use. The synthesis process remains cumbersome and hinders the large-scale production of defect-free layers. Furthermore, the material is highly sensitive to oxidation and suffers from phase instability. Scientists are now implementing strategies like defect engineering and surface functionalization to address these issues. Additionally, 2D-2D hybridization offers a path for tuning the band gap and improving carrier injection. These refinements are essential for creating stable sensors and imaging tools.
Integration into medical devices involves resolving issues such as interfacial charging and work function mismatch. However, if researchers overcome these barriers, borophene could transform multiple specialties. Specifically, it holds promise for flexible batteries in wearable monitors and advanced biosensors for point-of-care diagnostics. Furthermore, its high surface area makes it an ideal candidate for targeted drug delivery systems. Therefore, the ongoing research into borophene stability is crucial for its eventual commercialization in the healthcare sector.
Borophene is lighter, more flexible, and possesses higher electronic mobility than graphene. These properties allow for more sensitive detection of biological molecules at trace levels.
Currently, researchers are studying its biocompatibility. Strategies like surface passivation and functionalization are being developed to reduce toxicity and prevent rapid oxidation in biological environments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of your physician or other qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Li Z et al. Borophene: Crucial Challenges and the Way Forward. Adv Sci (Weinh). 2026 Mar 15. doi: 10.1002/advs.202517082. PMID: 41833012.
Pan D et al. Chiralized Borophene for Biomedical Imaging and Targeted Delivery. ACS Nano. 2024 May 8. doi: 10.1021/acsnano.4c01792.
Blundell R. Revolutionary materials in medicine: Borophene, graphene, and graphite. Independent Malta. 2024 June 23.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of borophene's unique properties, current synthesis challenges, and its transformative potential in biomedical sensors and drug delivery....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today